Some of these include greater emphasis on targeting epitopes close to the membrane that allow the greatest level of T-cell activation [221,224,226], greater emphasis on geometry of both binding arms that allows for strongest synapse formation and killing potency (c.f., Figure 8 [17]) and improvement in understanding and applying affinity to both the CD3ε and tumor antigen arms. This evidence concerns the gene CD3E and neoplasm.